Advertisement

Topics

Lumigan 03 | LUMIGAN [Allergan, Inc.] | BioPortfolio

15:25 EST 26th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

®ALLERGAN

LUMIGAN® (bimatoprostophthalmic solution)

0.03%

3 mL

sterile Rx only

ALLERGAN™

Rx

BIMATOPROSTOPHTHALMICSOLUTION 0.03%

LUMIGAN™

3 mL

sterile

FOR EXTERNAL USE ONLY

® ALLERGAN

LUMIGAN™

(BIMATOPROSTOPHTHALMICSOLUTION)0.03%

3 mL

sterile

® ALLERGAN

LUMIGAN™

(BIMATOPROSTOPHTHALMICSOLUTION)0.03%

K

3 mL

sterile

® ALLERGAN

LUMIGAN™

(BIMATOPROSTOPHTHALMICSOLUTION)0.03%

3 mL

sterile

® ALLERGAN

LUMIGAN™

(BIMATOPROSTOPHTHALMICSOLUTION)0.03%

3 mL

sterile

Manufacturer

Allergan, Inc.

Active Ingredients

Source

Drugs and Medications [5 Associated Drugs and Medications listed on BioPortfolio]

Lumigan [physicians total care, inc.]

These highlights do not include all the information needed to use LUMIGAN 0.01% and 0.03% (bimatoprost ophthalmic solution) safely and effectively. See full prescribing information for LUMIGAN. LUMIGA...

Lumigan [allergan, inc.]

These highlights do not include all the information needed to use LUMIGAN 0.01% safely and effectively. See full prescribing information for LUMIGAN 0.01%. LUMIGAN (bimatoprost ophthalmic solution) 0....

Bimatoprost [sandoz inc]

These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION.BIMATOPRO...

Bimatoprost [hi-tech pharmacal co., inc.]

These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION.BIMATOPRO...

Latisse [allergan, inc. ]

These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE (bimatoprost ophthalmic solution) 0.03% Initial ...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients

The purpose of this study is to assess the efficacy and safety of T4032 versus Lumigan.

The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye

The purpose of this study is to study changes in skin color that may be caused by using one of the three eye medicines: Xalatan, Travatan or lumigan.

Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes

Objective: To determine if Lumigan (bimatoprost) causes increased lash length when used in gel suspension applied to the base of the eyelashes. Methods: Subjects recruited from the Basc...

A Study of Bimatoprost 0.01% in the Clinical Setting

This is a study of bimatoprost 0.01% (LUMIGAN® 0.01%) in subjects with primary open-angle glaucoma (POAG) or ocular hypertension (OH) who require further treatment for elevated intraocula...

Lumigan Versus Cosopt

To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle...

PubMed Articles [0 Results]

None

Advertisement
Quick Search
Advertisement
Advertisement

 

Drugs and Medication Quicklinks


Searches Linking to this Drug Record